Study2013

Relevance of anti-inflammatory and antioxidant activities of exemestane and synergism with sulforaphane for disease prevention

Liu H, Talalay P

Proceedings of the National Academy of Sciences of the United States of America · 58 citations

Review labels

Funding not disclosedMechanisms only

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
In vitro/mechanistic study (classified by our AI screen)
Studied in
People, plus animal or lab work
Main outcome
Mechanisms only

Who paid for it

Funding
Funding not disclosed

Publication

Published
2013-11-04 · Proc Natl Acad Sci U S A · vol. 110 · issue 47 · pp. 19065–19070
Publisher
National Academy of Sciences
Cited
84 citations · more than 93% of similar papers · 3.4× the field average
Impact
Top 10% most cited in its field
References
39 works
Access
Open access (repository copy)
Research areas
Genomics, phytochemicals, and oxidative stress · Bioactive Compounds and Antitumor Agents · Reproductive System and Pregnancy
Keywords
Sulforaphane, Exemestane, Chemoprotective, Aromatase, Chemistry, Pharmacology, Biochemistry, Biology, Antioxidant, Internal medicine, Medicine, Cancer
MeSH
cell line, animals, mice, knockout, humans, mice, rats, chronic disease, reactive oxygen species, isothiocyanates, sulfoxides, androstadienes, luciferases, nad(p)h dehydrogenase (quinone), anti-inflammatory agents, antioxidants, oxidative stress, cytoprotection, drug synergism, nf-e2-related factor 2, nitric oxide synthase type ii, real-time polymerase chain reaction

2 authors

From US

  • Hua LiuJohns Hopkins University; Johns Hopkins Medicine
  • Paul TalalayJohns Hopkins University; Johns Hopkins Medicine

Abstract

Exemestane (6-methyleneandrosta-1,4-diene-3,17-dione) is a synthetic steroidal inhibitor of the aromatase reaction that catalyzes the terminal and rate-limiting step of the biosynthesis of estrogens. It is active clinically in preventing, delaying progression of, and treating mammary cancers, many of which are estrogen receptor-positive. A striking feature of the structure of exemestane is an extended system of conjugated Michael reaction functions, which is also characteristic of inducers of a broad network of chemoprotective genes regulated by the Keap1 (Kelch-like ECA-associated protein)/Nrf2 (nuclear factor E2-related factor 2)/ARE (antioxidant response element) signaling system. These genes are largely involved in xenobiotic metabolism and antioxidative and anti-inflammatory protection, as well as the synthesis and reduction of glutathione. We show here that exemestane transcriptionally activates NAD(P)H:quinone oxidoreductase 1 (NQO1) and heme oxygenase 1 (HO-1), typical chemoprotective gene products, in a wide variety of mouse, rat, and human cells. It protects several cell lines against oxidative toxicity of tert-butyl hydroperoxide and 4-hydroxynonenal, against free radical damage arising from hypoxia-reoxygenation, and against UVA radiation damage. Exemestane also inhibits the inflammatory increases in inducible nitric oxide synthase (iNOS) in mouse macrophages exposed to LPS (lipopolysaccharide), thereby resembling the isothiocyanate sulforaphane derived from broccoli. Remarkably, combinations of exemestane and sulforaphane act highly synergistically, and this property is also displayed by several other phytochemicals. Thus, exemestane has a wide range of previously unrecognized protective activities, probably unrelated to aromatase inhibition. Its potential for reducing the risk, not only of breast cancer, but also of other chronic diseases that arise from inflammation, oxidative stress, and DNA-damaging electrophiles, requires exploration, particularly in view of the synergism with other phytochemicals.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.